Scientists may have found a solution that can put an end to drug injections

The test device, called Soma, is shaped like the tortoise's shell

Capsules
Capsules
Gina Kolata | NYT
Last Updated : Feb 09 2019 | 11:17 PM IST
Here was the challenge for bioengineers: Find a way for patients to take drugs — like insulin or monoclonal antibodies used to treat cancers and other diseases — without injections.

The medicines are made of molecules too big to be absorbed through the stomach or intestines; in any event, the drugs would be quickly degraded by the body’s harsh digestive system.

Now, a team of scientists may have found a solution that delivers these drugs in a capsule a person can swallow. Their inspiration? A tortoise that always rights itself after rolling over.

The test device, called Soma, is shaped like the tortoise’s shell. Inside is a miniature post made of insulin. After the tiny device positions itself against the stomach wall, the post pops out and injects insulin. The device then travels through the colon and eventually is eliminated by the patient.

The device works in rats and pigs, the investigators reported on Thursday in the journal Science. The researchers — at M I T , Harvard and Novo Nordisk, the pharmaceutical company — hope to start testing Soma in humans in three years.

Outside experts said the device may well be a viable solution to the injection problem. “It’s a very new concept and a really cool idea,” said Edith Mathiowitz, a professor of medical science and engineering at Brown University.

While sounding like something out of science fiction, Soma synthesises a number of recent engineering advances, experts said.

“What they have done is taken ideas from many areas and integrated them,” said Tejal Desai, chair of bioengineering and therapeutic sciences at the University of California,  San Francisco.

The researchers knew that if they could get a drug through the wall of the stomach, the medicine would enter the bloodstream. Because the stomach does not have many pain receptors, a prick from the tiny post would not even be felt.

Creating a device to accomplish this required three key advances, said Giovanni Traverso, a gastroenterologist at Harvard’s Brigham and Women’s Hospital in Boston and a lead author of the paper. The first challenge was to make a device that would land on the stomach in a predictable way. For ideas, the researchers looked to nature — and discovered the leopard tortoise. An angled shell helps the tortoise roll back onto its feet no matter which way it falls. 

The engineers decided to imitate the tortoise’s shape with a tiny device that would always land on the wall of the stomach, in the right orientation, no matter how it tumbled down the esophagus. Next, they needed a cue that would trigger the release of a tiny post made of insulin that they would put in the device. 

“The stomach is moist and humid,” Traverso said. “That was the key clue.” 

That sort of environment will dissolve sugar, as a lozenge or candy dissolves in your mouth. 

The insulin needle was compressed like a spring and held in place with a thin disc of sugar. 

By controlling the size of the disc, the researchers were able to control how long the mechanism would stay intact. They decided on five minutes: When the sugar dissolved, the insulin post would pop out.

Finally, they had to make that tiny insulin post. The device that would hold it is small, the size of a pea, which restricted how much drug it could contain.



One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story